Qu Biologics Completes Enrollment of Randomized Clinical Trial in Crohn’s Disease|
Qu Biologics Inc. announced that it has completed enrollment of its QBECO-01 Crohn’s disease clinical trial. QBECO-01 is a 68-patient Phase I/II randomized, double-blind, placebo-controlled clinical trial in patients with moderate-to-severe Crohn’s disease. [Qu Biologics Inc.] Press Release
CPRIT Awards Faculty $19.6 Million for Research in Cervical, Breast, Lung, Colon, and Pediatric Cancers, and Cancer Biology
The Cancer Prevention and Research Institute of Texas (CPRIT) has awarded UT Southwestern Medical Center researchers more than $19.6 million in research grants to improve preventive, diagnostic, and therapeutic services relating to cervical, breast, lung, colon, and pediatric cancers, as well as to improve scientific understanding of cancer biology. [The University of Texas Southwestern Medical Center] Press Release
From our sponsor: Culturing hematopoietic stem and progenitor cells? Download the technical bulletin.